_id
690db3d2ccc777a4e85d0d0c
Ticker
AVTR
Name
Avantor Inc
Exchange
NYSE
Address
Radnor Corporate Center, Radnor, PA, United States, 19087
Country
USA
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
USD
Website
https://www.avantorsciences.com
Description
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Last Close
10.63
Volume
6607000
Current Price
11.51
Change
8.278457196613347
Last Updated
2025-11-28T12:36:37.742Z
Image
-
Ipo Date
2019-05-17T00:00:00.000Z
Market Cap
8004506112
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.26833483146067416
Sentiment Sources
89
Rating
3.7619
Target Price
13.6429
Strong Buy
6
Buy
4
Hold
11
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
1623800000
Cost Of Revenue
1097300000
Gross Profit
526500000
Operating Expenses
1175300000
Operating Income
-648800000
Interest Expense
44200000
Pretax Income
-689500000
Net Income
-711800000
Eps
-1.0441543200821475
Dividends Per Share
-
Shares Outstanding
681814859
Income Tax Expense
22300000
EBITDA
-540800000
Operating Margin
-39.95565956398571
Total Other Income Expense Net
-40700000
Cash
251900000
Short Term Investments
-
Receivables
1077700000
Inventories
795500000
Total Current Assets
2257200000
Property Plant Equipment
761600000
Total Assets
11675900000
Payables
691600000
Short Term Debt
219800000
Long Term Debt
3638100000
Total Liabilities
6105700000
Equity
5570200000
Depreciation
104500000
Change In Working Capital
20000000
Cash From Operations
207400000
Capital Expenditures
35700000
Cash From Investing
-
Cash From Financing
-369600000
Net Change In Cash
-197500000
PE
-
PB
1.4086329036659366
ROE
-12.778715306452193
ROA
-6.096318056852149
FCF
171700000
Fcf Percent
0.10573962310629388
Piotroski FScore
2
Health Score
34
Deep Value Investing Score
4.5
Defensive Investing Score
6
Dividend Investing Score
3
Economic Moat Investing Score
6.3
Garp Investing Score
3
Growth Investing Score
3
Momentum Investing Score
6.5
Net Net Investing Score
2.5
Quality Investing Score
3.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1623800000
Quarters > 0 > income Statement > cost Of Revenue
1097300000
Quarters > 0 > income Statement > gross Profit
526500000
Quarters > 0 > income Statement > operating Expenses
1175300000
Quarters > 0 > income Statement > operating Income
-648800000
Quarters > 0 > income Statement > interest Expense
44200000
Quarters > 0 > income Statement > pretax Income
-689500000
Quarters > 0 > income Statement > net Income
-711800000
Quarters > 0 > income Statement > eps
-1.0441543200821475
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
681700000
Quarters > 0 > income Statement > income Tax Expense
22300000
Quarters > 0 > income Statement > EBITDA
-540800000
Quarters > 0 > income Statement > operating Margin
-39.95565956398571
Quarters > 0 > income Statement > total Other Income Expense Net
-40700000
Quarters > 0 > balance Sheet > cash
251900000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1077700000
Quarters > 0 > balance Sheet > inventories
795500000
Quarters > 0 > balance Sheet > total Current Assets
2257200000
Quarters > 0 > balance Sheet > property Plant Equipment
761600000
Quarters > 0 > balance Sheet > total Assets
11675900000
Quarters > 0 > balance Sheet > payables
691600000
Quarters > 0 > balance Sheet > short Term Debt
219800000
Quarters > 0 > balance Sheet > long Term Debt
3638100000
Quarters > 0 > balance Sheet > total Liabilities
6105700000
Quarters > 0 > balance Sheet > equity
5570200000
Quarters > 0 > cash Flow > net Income
-711800000
Quarters > 0 > cash Flow > depreciation
104500000
Quarters > 0 > cash Flow > change In Working Capital
20000000
Quarters > 0 > cash Flow > cash From Operations
207400000
Quarters > 0 > cash Flow > capital Expenditures
35700000
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-369600000
Quarters > 0 > cash Flow > net Change In Cash
-197500000
Quarters > 0 > ratios > PE
-1.0441543200821475
Quarters > 0 > ratios > PB
1.4086329036659366
Quarters > 0 > ratios > ROE
-12.778715306452193
Quarters > 0 > ratios > ROA
-6.096318056852149
Quarters > 0 > ratios > FCF
171700000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.10573962310629388
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1683400000
Quarters > 1 > income Statement > cost Of Revenue
1129300000
Quarters > 1 > income Statement > gross Profit
554100000
Quarters > 1 > income Statement > operating Expenses
425300000
Quarters > 1 > income Statement > operating Income
128800000
Quarters > 1 > income Statement > interest Expense
43400000
Quarters > 1 > income Statement > pretax Income
81700000
Quarters > 1 > income Statement > net Income
64700000
Quarters > 1 > income Statement > eps
0.09489586388970372
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
681800000
Quarters > 1 > income Statement > income Tax Expense
17000000
Quarters > 1 > income Statement > EBITDA
227800000
Quarters > 1 > income Statement > operating Margin
7.651182131400737
Quarters > 1 > income Statement > total Other Income Expense Net
-47100000
Quarters > 1 > balance Sheet > cash
449400000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1149400000
Quarters > 1 > balance Sheet > inventories
779800000
Quarters > 1 > balance Sheet > total Current Assets
2514600000
Quarters > 1 > balance Sheet > property Plant Equipment
759000000
Quarters > 1 > balance Sheet > total Assets
12776900000
Quarters > 1 > balance Sheet > payables
708800000
Quarters > 1 > balance Sheet > short Term Debt
1254300000
Quarters > 1 > balance Sheet > long Term Debt
2988200000
Quarters > 1 > balance Sheet > total Liabilities
6491000000
Quarters > 1 > balance Sheet > equity
6285900000
Quarters > 1 > cash Flow > net Income
7700000
Quarters > 1 > cash Flow > depreciation
101300000
Quarters > 1 > cash Flow > change In Working Capital
-20200000
Quarters > 1 > cash Flow > cash From Operations
154400000
Quarters > 1 > cash Flow > capital Expenditures
29600000
Quarters > 1 > cash Flow > cash From Investing
-28600000
Quarters > 1 > cash Flow > cash From Financing
-6900000
Quarters > 1 > cash Flow > net Change In Cash
133300000
Quarters > 1 > ratios > PE
0.09489586388970372
Quarters > 1 > ratios > PB
1.2484318872396951
Quarters > 1 > ratios > ROE
1.0292877710431283
Quarters > 1 > ratios > ROA
0.5063826123707629
Quarters > 1 > ratios > FCF
124800000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.07413567779493882
Quarters > 1 > health Score
48
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1581400000
Quarters > 2 > income Statement > cost Of Revenue
1046500000
Quarters > 2 > income Statement > gross Profit
534900000
Quarters > 2 > income Statement > operating Expenses
387500000
Quarters > 2 > income Statement > operating Income
147400000
Quarters > 2 > income Statement > interest Expense
42200000
Quarters > 2 > income Statement > pretax Income
85700000
Quarters > 2 > income Statement > net Income
64500000
Quarters > 2 > income Statement > eps
0.09451934349355216
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
682400000
Quarters > 2 > income Statement > income Tax Expense
21200000
Quarters > 2 > income Statement > EBITDA
227600000
Quarters > 2 > income Statement > operating Margin
9.320854938661945
Quarters > 2 > income Statement > total Other Income Expense Net
-61700000
Quarters > 2 > balance Sheet > cash
315700000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1096300000
Quarters > 2 > balance Sheet > inventories
750100000
Quarters > 2 > balance Sheet > total Current Assets
2282400000
Quarters > 2 > balance Sheet > property Plant Equipment
736300000
Quarters > 2 > balance Sheet > total Assets
12326400000
Quarters > 2 > balance Sheet > payables
680100000
Quarters > 2 > balance Sheet > short Term Debt
827500000
Quarters > 2 > balance Sheet > long Term Debt
3279200000
Quarters > 2 > balance Sheet > total Liabilities
6228200000
Quarters > 2 > balance Sheet > equity
6098200000
Quarters > 2 > cash Flow > net Income
60400000
Quarters > 2 > cash Flow > depreciation
99700000
Quarters > 2 > cash Flow > change In Working Capital
-89100000
Quarters > 2 > cash Flow > cash From Operations
109300000
Quarters > 2 > cash Flow > capital Expenditures
28000000
Quarters > 2 > cash Flow > cash From Investing
-28900000
Quarters > 2 > cash Flow > cash From Financing
-33600000
Quarters > 2 > cash Flow > net Change In Cash
53800000
Quarters > 2 > ratios > PE
0.09451934349355216
Quarters > 2 > ratios > PB
1.2879905545898789
Quarters > 2 > ratios > ROE
1.0576891541766422
Quarters > 2 > ratios > ROA
0.5232671339563862
Quarters > 2 > ratios > FCF
81300000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.05141014291134438
Quarters > 2 > health Score
46
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1686600000
Quarters > 3 > income Statement > cost Of Revenue
1123700000
Quarters > 3 > income Statement > gross Profit
562900000
Quarters > 3 > income Statement > operating Expenses
-75200000
Quarters > 3 > income Statement > operating Income
638100000
Quarters > 3 > income Statement > interest Expense
44900000
Quarters > 3 > income Statement > pretax Income
584200000
Quarters > 3 > income Statement > net Income
500400000
Quarters > 3 > income Statement > eps
0.7329720228504467
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
682700000
Quarters > 3 > income Statement > income Tax Expense
83800000
Quarters > 3 > income Statement > EBITDA
730000000
Quarters > 3 > income Statement > operating Margin
37.83351120597652
Quarters > 3 > income Statement > total Other Income Expense Net
-53900000
Quarters > 3 > balance Sheet > cash
261900000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1034500000
Quarters > 3 > balance Sheet > inventories
731500000
Quarters > 3 > balance Sheet > total Current Assets
2146600000
Quarters > 3 > balance Sheet > property Plant Equipment
708100000
Quarters > 3 > balance Sheet > total Assets
12114500000
Quarters > 3 > balance Sheet > payables
662800000
Quarters > 3 > balance Sheet > short Term Debt
821100000
Quarters > 3 > balance Sheet > long Term Debt
3234700000
Quarters > 3 > balance Sheet > total Liabilities
6157800000
Quarters > 3 > balance Sheet > equity
5956700000
Quarters > 3 > cash Flow > net Income
500400000
Quarters > 3 > cash Flow > depreciation
100900000
Quarters > 3 > cash Flow > change In Working Capital
-53400000
Quarters > 3 > cash Flow > cash From Operations
173300000
Quarters > 3 > cash Flow > capital Expenditures
27500000
Quarters > 3 > cash Flow > cash From Investing
558500000
Quarters > 3 > cash Flow > cash From Financing
-755300000
Quarters > 3 > cash Flow > net Change In Cash
-45600000
Quarters > 3 > ratios > PE
0.7329720228504467
Quarters > 3 > ratios > PB
1.3191661490422548
Quarters > 3 > ratios > ROE
8.400624506857824
Quarters > 3 > ratios > ROA
4.130587312724421
Quarters > 3 > ratios > FCF
145800000
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
0.0864461045891142
Quarters > 3 > health Score
57
Valuation > metrics > PE
-1.0441543200821475
Valuation > metrics > PB
1.4086329036659366
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-12.778715306452193
Profitability > metrics > ROA
-31.53464469253943
Profitability > metrics > Net Margin
-0.43835447715235865
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.096136583964669
Risk > metrics > Interest Coverage
-14.678733031674208
Risk > final Score
-29
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.4766293614219883
Liquidity > metrics > Quick Ratio
1.6037963572525784
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
100
Prev Valuations > 2
100
Prev Profitabilities > 0
16
Prev Profitabilities > 1
17
Prev Profitabilities > 2
77
Prev Risks > 0
42
Prev Risks > 1
44
Prev Risks > 2
70
Prev Liquidities > 0
76
Prev Liquidities > 1
88
Prev Liquidities > 2
84
Updated At
2025-12-12T00:09:14.923Z
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHow Securities Lawsuits And Insider Buying At Avantor (AVTR) Have Changed Its Investment Story Yahoo Finance UK
Read more →What Avantor (AVTR)'s Board Shake-Up And Lawsuits Over Competitive Disclosures Mean For Shareholders simplywall.st
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$13.6429
Analyst Picks
Strong Buy
6
Buy
4
Hold
11
Sell
0
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Medium
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 74.71% of the total shares of Avantor Inc
1.
Dodge & Cox(17.2256%)
since
2025/06/30
2.
BlackRock Inc(10.5473%)
since
2025/06/30
3.
Vanguard Group Inc(9.513%)
since
2025/06/30
4.
T. Rowe Price Investment Management,Inc.(8.2877%)
since
2025/06/30
5.
Barrow Hanley Mewhinney & Strauss LLC(4.5753%)
since
2025/06/30
6.
State Street Corp(3.4448%)
since
2025/06/30
7.
Amvescap Plc.(2.3372%)
since
2025/06/30
8.
Manufacturers Life Insurance Co(2.3344%)
since
2025/06/30
9.
New Mountain Capital, L.L.C.(2.0536%)
since
2025/06/30
10.
Clarkston Capital Partners, LLC(2.0509%)
since
2025/06/30
11.
Geode Capital Management, LLC(1.7464%)
since
2025/06/30
12.
Dimensional Fund Advisors, Inc.(1.599%)
since
2025/06/30
13.
HHG PLC(1.4215%)
since
2025/06/30
14.
Sam Sustainable Asset Management Ltd(1.2801%)
since
2025/06/30
15.
NORGES BANK(1.1788%)
since
2025/06/30
16.
Bank of America Corp(1.0994%)
since
2025/06/30
17.
Bessemer Group Inc(1.0408%)
since
2025/06/30
18.
FMR Inc(1.0144%)
since
2025/06/30
19.
Morgan Stanley - Brokerage Accounts(1.0079%)
since
2025/06/30
20.
Northern Trust Corp(0.9556%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.